ANGO
AngioDynamics·NASDAQ
--
--(--)
--
--(--)
ANGO fundamentals
AngioDynamics (ANGO) expects to report earnings on Jan 6, 2026, with estimated revenue of 76.43M (YoY +4.68%), and EPS at -0.1 (YoY -150.00%).
Revenue estimate / YoY
76.43M
+4.68%
EPS estimate / YoY
-0.1
-150.00%
Report date
Jan 6, 2026
ANGO Earnings Call Summary for Q2,2026
- Revenue Growth: 8.8% YoY to $74.7M, Med Tech up 13% with Auryon +18.6%.
- Regulatory Wins: 3 approvals for thrombectomy portfolio, enabling broader clinical applications.
- Financial Strength: Adjusted EBITDA +84%, gross margin 56.4%, cash flow positive Q2.
- Strategic Moves: Raised guidance, international expansion, and R&D investment for long-term growth.
- Leadership Transition: CEO succession planned for FY2027 amid strong performance.
EPS
Revenue
Revenue & Expenses
ANGO has released its 2026 Q2 earnings report, with revenue of 79.43M, reflecting a YoY change of 9.04%, and net profit of -6.35M, showing a YoY change of 40.86%. The Sankey diagram below clearly presents ANGO's revenue sources and cost distribution.
Key Indicators
AngioDynamics (ANGO) key financial stats and ratios, covering profitability, financial health, and leverage.
AngioDynamics (ANGO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
AngioDynamics (ANGO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
AngioDynamics (ANGO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does AngioDynamics (ANGO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track AngioDynamics (ANGO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from AngioDynamics's earnings call?What is the market's earnings forecast for AngioDynamics next quarter?What guidance did AngioDynamics's management provide for the next earnings period?What is AngioDynamics's latest dividend and current dividend yield?What factors drove the changes in AngioDynamics's revenue and profit?What is the revenue and EPS growth rate for AngioDynamics year over year?Did AngioDynamics beat or miss consensus estimates last quarter?What were the key takeaways from AngioDynamics’s earnings call?
